Veterinary Medicines

XEDEN 15 MG TABLET FOR CATS

Authorised
  • Enrofloxacin
Download as PDF

Product identification

Medicine name:
XEDEN 15 MG TABLET FOR CATS
Xeden 15 mg
Active substance:
  • Enrofloxacin
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Enrofloxacin
    15.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • Cardboard box with 2 blisters of 12 tablets
  • Cardboard box with 5 blisters of 12 tablets
  • Cardboard box with 8 blisters of 12 tablets
  • Cardboard box with 10 blisters of 12 tablets
  • Cardboard box with 1 blister of 12 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Tiergesundheit GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 401076.00.00
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0186/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."